Cargando…
Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization
Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...
Autores principales: | Wang, Shuo, Zhang, Chao, Li, Jiawei, Niyazi, Sidikejiang, Zheng, Long, Xu, Ming, Rong, Ruiming, Yang, Cheng, Zhu, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477572/ https://www.ncbi.nlm.nih.gov/pubmed/28383559 http://dx.doi.org/10.1038/cddis.2017.104 |
Ejemplares similares
-
A novel cytoprotective peptide protects mesenchymal stem cells against mitochondrial dysfunction and apoptosis induced by starvation via Nrf2/Sirt3/FoxO3a pathway
por: Wang, Shuo, et al.
Publicado: (2017) -
Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction
por: Zheng, Long, et al.
Publicado: (2017) -
The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury
por: Zhang, Chao, et al.
Publicado: (2017) -
Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells
por: Zhang, Chao, et al.
Publicado: (2014) -
CHBP induces stronger immunosuppressive CD127(+) M-MDSC via erythropoietin receptor
por: Li, Jiawei, et al.
Publicado: (2021)